Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 5
2021 8
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study.
Solana-Altabella A, Megías-Vericat JE, Ballesta-López O, Boluda B, Cano I, Acuña-Cruz E, Rodríguez-Veiga R, Torres-Miñana L, Sargas C, Sanz MÁ, Borrell-García C, López-Briz E, Poveda-Andrés JL, De la Rubia J, Montesinos P, Martínez-Cuadrón D. Solana-Altabella A, et al. Among authors: ballesta lopez o. Cancers (Basel). 2022 Apr 11;14(8):1921. doi: 10.3390/cancers14081921. Cancers (Basel). 2022. PMID: 35454828 Free PMC article.
Emerging FLT3 inhibitors for the treatment of acute myeloid leukemia.
Solana-Altabella A, Ballesta-López O, Megías-Vericat JE, Martínez-Cuadrón D, Montesinos P. Solana-Altabella A, et al. Among authors: ballesta lopez o. Expert Opin Emerg Drugs. 2022 Mar;27(1):1-18. doi: 10.1080/14728214.2021.2009800. Epub 2022 Jan 25. Expert Opin Emerg Drugs. 2022. PMID: 35076348
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R, Méndez R, Palanques-Pastor T, Ballesta-López O, Borrás Almenar C, Megías Vericat JE, López-Briz E, Font-Noguera I, Menéndez Villanueva R, Román Iborra JA, Poveda Andrés JL. Iglesias Gómez R, et al. Among authors: ballesta lopez o. Eur J Hosp Pharm. 2022 Mar;29(e1):e41-e45. doi: 10.1136/ejhpharm-2021-002741. Epub 2021 Jul 28. Eur J Hosp Pharm. 2022. PMID: 34321249 Free PMC article.
Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain.
Boluda B, Solana-Altabella A, Cano I, Acuña-Cruz E, Rodríguez-Veiga R, Ballesta-López O, Megías-Vericat JE, Martínez-Cuadrón D, Gómez I, Solves P, Lorenzo I, Piñana JL, Sanz J, Guerreiro M, Montoro Gómez J, Díaz-González A, Marco J, Blanco A, Sanz MÁ, Montesinos P. Boluda B, et al. Among authors: ballesta lopez o. J Clin Apher. 2021 Aug;36(4):612-620. doi: 10.1002/jca.21901. Epub 2021 May 8. J Clin Apher. 2021. PMID: 33964038 Free PMC article.
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
Megías-Vericat JE, Martínez-Cuadrón D, Herrero MJ, Rodríguez-Veiga R, Solana-Altabella A, Boluda B, Ballesta-López O, Cano I, Acuña-Cruz E, Cervera J, Poveda JL, Sanz MÁ, Aliño SF, Montesinos P. Megías-Vericat JE, et al. Among authors: ballesta lopez o. Pharmacogenet Genomics. 2021 Aug 1;31(6):133-139. doi: 10.1097/FPC.0000000000000431. Pharmacogenet Genomics. 2021. PMID: 33675324
Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain.
Solana-Altabella A, Boluda B, Rodríguez-Veiga R, Cano I, Acuña-Cruz E, Blanco A, Marco-Ayala J, de la Puerta R, Díaz-González Á, Piñana JL, Sanz J, Sempere A, Cervera J, Barragán E, Sargas C, Ballesta-López O, Megías-Vericat JE, Martínez-Cuadrón D, Sanz MÁ, Montesinos P. Solana-Altabella A, et al. Among authors: ballesta lopez o. Eur J Haematol. 2021 May;106(5):724-733. doi: 10.1111/ejh.13604. Epub 2021 Mar 5. Eur J Haematol. 2021. PMID: 33609315
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Megías-Vericat JE, Martínez-Cuadrón D, Herrero MJ, Rodríguez-Veiga R, Solana-Altabella A, Boluda B, Ballesta-López O, Cano I, Acuña-Cruz E, Cervera J, Poveda JL, Sanz M, Aliño SF, Montesinos P. Megías-Vericat JE, et al. Among authors: ballesta lopez o. Leuk Lymphoma. 2021 Mar;62(3):659-668. doi: 10.1080/10428194.2020.1839650. Epub 2020 Nov 2. Leuk Lymphoma. 2021. PMID: 33135528
14 results